James (Jim) T. LaFrance

Mr. LaFrance has served on our board of directors since December 2015. Mr. LaFrance has over thirty five years of diagnostic industry experience working since January 2015 as a sales, marketing, strategy development and commercial operational management consultant for LaFrance Consulting LLC, a firm he founded. He current serves on two additional boards, Aspira Women's health (Nasda: AWH); formerly Vermillion, Inc.(Nasdaq: VRMC) as chairman, and as an independent director of privately held Personal Genome Diagnostics in Baltimore, Maryland. He served as interim Chief Executive Officer of Vermillion, Inc. in 2014 and as Chief Executive Officer of Omnyx, LLC for GE Healthcare from 2012 to 2013. Mr. LaFrance held a series of Senior Management roles at Ventana Medical Systems (now Roche Tissue Diagnostics), or Ventana, including general management of the North American and international commercial operations. Prior to working for Ventana, Mr. LaFrance served in leadership roles in strategic marketing and business development at Bayer Diagnostics. He earned a Bachelor of Arts degree in Economics from the University of Connecticut and holds a Masters in Business Administration from the University of Notre Dame.